Page last updated: 2024-10-22

dan 2163 and Cognitive Dysfunction

dan 2163 has been researched along with Cognitive Dysfunction in 2 studies

Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Raafat, RS1
Habib, MZ1
AbdElfattah, AA1
Olama, NK1
Abdelraouf, SM1
Hendawy, N1
Kamal, KA1
Nawishy, SA1
Aboul-Fotouh, S1
Park, CH1
Park, TW1
Yang, JC1
Lee, KH1
Huang, GB1
Tong, Z1
Park, MS1
Chung, YC1

Trials

1 trial available for dan 2163 and Cognitive Dysfunction

ArticleYear
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
    International clinical psychopharmacology, 2012, Volume: 27, Issue:2

    Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Bli

2012

Other Studies

1 other study available for dan 2163 and Cognitive Dysfunction

ArticleYear
Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats.
    International immunopharmacology, 2023, Volume: 124, Issue:Pt A

    Topics: Amisulpride; Animals; beta Catenin; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunct

2023